Section Arrow
Quote
RGC.NASDAQ
- Regencell Bioscience Holdings Limited
Quotes are at least 15-min delayed:2026/11/14 14:46 EST
Regular Hours
Last
 4.94
-0.185 (-3.61%)
Day High 
5.08 
Prev. Close
5.125 
1-M High
11.305 
Volume 
119.34K 
Bid
4.9
Ask
5.19
Day Low
4.71 
Open
5.08 
1-M Low
5.01 
Market Cap 
2.54B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.65 
20-SMA 7.16 
50-SMA 6.82 
52-W High 69 
52-W Low 4.51 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.02/--
Enterprise Value
2.54B
Balance Sheet
Book Value Per Share
0.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AKANAkanda Corp.1.36+0.6883+102.47%-- 
HLNHaleon plc9.17+0.08+0.88%18.97PE
HIMSHims & Hers Health19.73------ 
TEVATeva Pharmaceutical Industries Limited44.5+0.85+1.95%102.3PE
VTRSViatris20.82+0.15+0.73%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Regencell Bioscience Holdings Ltd is an early-stage bioscience company that focuses on research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, specifically ADHD and ASD. Its goal is to save and improve the lives of patients, their families and caregivers and become a market leader for the natural and holistic treatment globally. The company operates and manages its business as a single segment - in the research and development of the company's product candidates.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.